STOCK TITAN

Yale Transaction Finders (YTFD) Financials

YTFD OTC
Trailing 12 months to June 30, 2026
Revenue Not reported for the trailing 12 months
Net Income -$42K YoY not available
EPS (Diluted) Not reported for the trailing 12 months
Operating Cash Flow -$34K n/m YoY
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the YTFD SEC filings page.

This page shows Yale Transaction Finders (YTFD) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI YTFD FY2025

The statements depict a tiny, persistently loss-making balance sheet financed by obligations far larger than its recorded assets.

In FY2025, operating cash flow of -$31K nearly matched the operating loss of $34K, indicating that reported losses were translating into cash use rather than being dominated by noncash charges. Financing cash flow of $38K more than offset that operating deficit, revealing reliance on financing to fund routine activity.

Liabilities outweighed assets by a wide margin: they increased from $138K in FY2024 to $185K in FY2025, while equity remained negative at -$167K. This is a liability-heavy structure, not one supported by a substantial asset base.

Return on assets improved by 147.0% percentage points to -232.2% in FY2025 as assets expanded, but the company still recorded a net loss of $40K. Lower selling, general and administrative expense of 8.9% did not eliminate the operating loss, so the improvement reflects balance-sheet changes as well as expense reduction.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

We do not publish a peer-relative financial health score for Yale Transaction Finders, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.

Piotroski F-Score Partial
3/5

Yale Transaction Finders passes 3 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 2 of 4 profitability signals pass, all 1 leverage/liquidity signals pass.

Interest Coverage At Risk
N/A

Yale Transaction Finders reported an operating loss of $34K against $7K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Net Income
-$9K
YoYn/m
QoQn/m

Yale Transaction Finders reported a net loss of $9K in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Revenue

Not reported for Q2 2026.

EBITDA

Not reported for Q2 2026.

EPS (Diluted)

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt
$13K
YoY+45.4%
QoQ+66.5%

Yale Transaction Finders held $13K in cash as of Q2 2026; no long-term debt figure is on record for that period.

Shares Outstanding
5M
YoY0.0%
QoQ0.0%
5Y CAGR0.0%
10Y CAGR0.0%

Yale Transaction Finders had 5M shares outstanding in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

None of these metrics is reported for Q2 2026.

Capital Allocation

None of these metrics is reported for Q2 2026.

YTFD Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

YTFD quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
SG&A Expenses$7K+40.9%$7K-11.6%$16K$5K+18.0%$5K-60.6%$8KN/A$4K
Operating Income-$7Kn/m-$7Kn/m-$16K-$5Kn/m-$5Kn/m-$8KN/A-$4K
Interest Expense$2K+23.2%$2K+31.6%N/A$2K+31.7%$2K+35.5%$1K+61.1%N/A$1K+58.9%
Net Income-$9Kn/m-$9Kn/m-$18K-$7Kn/m-$7Kn/m-$9KN/A-$6K
EPS (Basic)$0.00n/m$0.00n/m-$0.01n/m$0.00n/m$0.00n/m$0.00n/m$0.00n/m$0.00n/m
Diluted Shares (Avg)5M0.0%5M0.0%N/AN/A5M5MN/AN/A

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, EBITDA, Income Tax, EPS (Diluted).

YTFD Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

YTFD quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$13K+45.4%$8K+22.1%$17K+55.7%$3K-5.0%$9K+63.2%$6K+1364.3%$11K+329.3%$3K+690.6%
Cash & Equivalents$13K+45.4%$8K+22.1%$17K+55.7%$3K-5.0%$9K+63.2%$6K+1364.3%$11K+329.3%$3K+690.6%
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Total Liabilities$198K+30.6%$184K+29.0%$185K+33.7%$153K+31.3%$152K+34.4%$142K+51.9%$138K+58.4%$116K+63.1%
Total Equity-$185Kn/m-$176Kn/m-$167Kn/m-$150Kn/m-$143Kn/m-$136Kn/m-$127Kn/m-$113Kn/m
Retained Earnings-$1.4Mn/m-$1.4Mn/m-$1.4Mn/m-$1.4Mn/m-$1.4Mn/m-$1.4Mn/m-$1.4Mn/m-$1.3Mn/m

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Goodwill, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

YTFD Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

YTFD quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow-$12Kn/m-$10Kn/m-$6Kn/m-$6Kn/m-$15Kn/m-$5K-$7Kn/m-$2K
Financing Cash FlowN/AN/A$20K+33.3%$0n/mN/AN/A$15K+87.5%$0n/m

Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Dividends Paid, Share Buybacks.

YTFD Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

YTFD quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Return on Assets-71.6%+4.6pp-114.3%+32.2pp-101.4%-214.6%-46.3pp-76.2%+185.2pp-146.4%N/A-168.3%

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Current Ratio, Debt-to-Equity, Liabilities-to-Equity, Asset Turnover, FCF Margin.

Note: Shareholder equity is negative (-$167K), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Yale Transaction Finders YTFD FY2025 N/A -$40K N/A N/A —
Metalink Ltd MTLK FY2025 N/A $86K N/A $271K —
Intl Media Acq Corp A IMAQ FY2026 N/A -$345K N/A $71.8M —
Chain Bridge I A CBRRF FY2025 N/A -$1.3M N/A $63.9M —

Frequently Asked Questions

No, Yale Transaction Finders (YTFD) reported a net loss of $42K over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net loss of $40K.

Yale Transaction Finders (YTFD) recorded an outflow of $31K in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Yale Transaction Finders (YTFD) had $17K in total assets as of fiscal year 2025, including both current and long-term assets.

Yale Transaction Finders (YTFD) had 5M shares outstanding as of fiscal year 2025.

Yale Transaction Finders (YTFD) had a return on assets of -232.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Yale Transaction Finders (YTFD) has negative shareholder equity of -$167K as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Yale Transaction Finders (YTFD) has a Piotroski F-Score of 3 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Yale Transaction Finders (YTFD) reported an operating loss of $34K against $7K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top